For close to two decades Purdue has engaged in many initiatives to stem prescription opioid abuse.
Click on the boxes below to see our collaborative efforts with states, communities, industry partners and law enforcement.
All opioids, including those with abuse-deterrent properties, expose users to the risks of addiction, abuse, and misuse which can lead to overdose and death.
Purdue developed the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) system…
Purdue developed the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) system to detect and study abuse, misuse, and diversion on a nationwide basis. Purdue transferred ownership of RADARS in 2006 to not-for-profit Denver Health and Hospital Authority’s Rocky Mountain Poison and Drug Center. Purdue transferred the system to an independent third party which allowed pharmaceutical companies and government agencies to more readily access valuable data on opioid abuse and diversion.
Purdue developed and deployed Radio Frequency ID technology to track medication bottles…
Purdue developed and deployed a bottle tracking program…
Purdue supported the National Sheriffs’ Association’s (NSA) “Saving Lives” program…
Purdue provided a $3.1 million grant to form a public-private partnership with the Commonwealth of Virginia…
Purdue has been working with Geisinger Health System […] on a study of interdisciplinary pain treatment…
Purdue partnered with North Carolina organizations Project Lazarus…
Purdue partnered with North Carolina organizations Project Lazarus – a non-profit providing training and technical assistance to communities and clinicians addressing prescription medication issues – and Safe Kids North Carolina to support state-wide medicine disposal activities and conduct research to evaluate the impact of community-based prevention programs on opioid-related overdoses, abuse, and diversion, spending approximately $600,000.
Purdue became a proud member of the Prescription Drug Safety Network…
Purdue supported NADDI with $1.77 million grant to launch National PDMP Enhanced Data Exchange (NPEDE)…
Purdue began accelerating the development of an opioid overdose reversal agent…
Purdue began accelerating the development of an opioid overdose reversal agent, committing to spend approximately $10+ million on research between 2018 and 2020. On March 13, 2019, Purdue announced that the FDA has granted Fast Track designation to nalmefene hydrochloride (HCl) injection, the company’s investigational opioid antagonist for the emergency treatment of known or suspected opioid overdose. As part of Purdue’s commitment to advancing meaningful solutions to address the opioid crisis, the company will work to bring forward this option with the commitment not to profit from any future sales of this drug.
Purdue provided a $3.42 million grant to Harm Reduction Therapeutics…
Purdue has spent approximately $1 billion to develop opioids with abuse-deterrent properties.
Purdue has frequently conducted and supported discovery research to develop non-opioid pain medications…
Purdue has frequently conducted and supported discovery research to develop non-opioid pain medications, spending approximately $400 million from 2000-2014. In January 2019, Purdue forged a partnership with Alivio Therapeutics to leverage the company’s inflammation-targeting technology to develop a non-opioid pain treatment.
Purdue provided more than $4 million to develop “Painfully Obvious,” a prescription drug abuse awareness program…
Purdue developed RxPATROL (Pattern Analysis Tracking Robberies and Other Losses)…
Purdue provided funding of approximately $2.7 million to support the Partnership for Drug-Free America…
Beginning in 2004 extending through 2016, Purdue provided funding of approximately $2.7 million to support the Partnership for Drug-Free America (later named Drug-Free Kids). Purdue’s contribution supported prevention education, a toll-free parent hotline in both Spanish and English, and “Time to Act,” a community education program and website for parents, guiding them in step-by-step action if they think or know their child is using drugs or drinking alcohol.
Purdue spent over $1.35 million to create […] “Communities That Care”
Purdue supported the National Association of Drug Diversion Investigators (NADDI)…
Purdue provided a $1 million grant to the National Association of Boards of Pharmacy (NABP) to help launch its InterConnect hub…
Purdue provided a $1 million grant to the National Association of Boards of Pharmacy (NABP) to help launch its InterConnect hub, which is designed to enable healthcare professionals to track prescriptions for monitored drugs in other states and help detect “doctor shopping” across state lines, while also protecting patients’ privacy.
Purdue shared the CDC Guideline for Prescribing Opioids for Chronic Pain with over 140,000 healthcare providers…
Purdue supported the pregnancy recovery pilot program…
Purdue supported Ironton/Lawrence County Ohio’s Pay for Success (Recovery to Workforce) Model…
Purdue gave $1 million to the Substance Use Disorder Residential Services Treatment Facility in Indiana.
Purdue supported Domus Kids – a nonprofit supporting struggling students in the Stamford, Conn. area…
Purdue supported the University of Delaware’s research intervention for new mothers in substance use recovery…
Purdue supported To the Moon and Back…
Purdue provided grants to the Connecticut Child Guidance Center…
Purdue funded youth-focused recovery outreach and community teams in Hamden, Conn. …
Purdue provided a $3.42 million grant to Harm Reduction Therapeutics…
Purdue provided financial support to New York’s “Keep It Moving” for 2,4000 naloxone cases and kit contents…
Purdue provided $150,000 to Innovative Support to Emergencies Diseases and Disasters (“InStedd”)…
Purdue gave $50,000 to the Great Circle Academy Recovery School in Missouri.
Purdue supported Generations United with a $100,000 grant to provide prevention information and education to grandfamilies…
Purdue provided support to Marshall University to research a translational model for neonatal abstinence syndrome.
Purdue provided a $125,000 grant to the Indiana Chamber of Commerce Foundation for a “Recovery to Workforce Program” …
Purdue provided grants to the Institute for Excellence in Government…
Purdue provided grants to the “Ready to Work” program at Pacific House, a men’s shelter in Stamford, Conn.
Purdue supported the Governor’s Prevention Partnership in Connecticut with a $50,000 grant…
Purdue provided a $267,000 grant for Tennessee’s Renewal House…
Purdue supported Domus Kids – a nonprofit supporting struggling students in the Stamford, Conn. area…
Purdue provided a $50,000 grant to the City University of New York’s Research Foundation…
Purdue uses comprehensive anti-diversion safety and surveillance processes to track shipments from manufacturing plants.
Purdue has provided approximately 1.2 million placebo tablets to over 1,000 law enforcement agencies since 2004.
Purdue began a program to provide tamper-resistant prescription pads at no cost to healthcare professionals…
Purdue voluntarily developed a RiskMAP…
Purdue worked with The Governor’s Prevention Partnership in Connecticut on substance abuse education…
Purdue developed and distributed an education campaign […] about safe medication storage and disposal.
Purdue distributed more than 47,000 prescription medication identification cards […] to law enforcement officers…
Purdue distributed more than 47,000 prescription medication identification cards created by the National Association of Drug Diversion Investigators (NADDI) to law enforcement officers in 210 agencies in 40 states. These cards were created to assist law enforcement in identifying tablets seized during arrests.
Purdue worked with partners to develop the Controlled Substances Patterns of Utilization Requiring Evaluation (CS PURE)…
Purdue supported states that were considering adopting Prescription Drug Monitoring Programs (PDMPs).
Crime Stoppers USA and Purdue partnered to publicize descriptions of suspects involved in the illegal diversion of prescription medication…
Purdue supported the National Community Pharmacists Association’s (NCPA)…
Purdue began supporting Community Anti-Drug Coalitions of America (CADCA) programs…
Purdue provided funding to support the U.S. Conference of Mayors’ prescription drug abuse awareness campaign.
Purdue provided $90,000 to support the NCPA’s Prescription Drug Safety Awards.
Purdue launched the SafeguardMyMeds.org website and a public service campaign…
Purdue supported the National Council on Patient Information and Education and the Substance Abuse and Mental Health Services Administration (SAMHSA) with grants…
Between 2010–2015, Purdue supported the National Council on Patient Information and Education and the Substance Abuse and Mental Health Services Administration (SAMHSA) with grants totaling approximately $271,000 to help prevent teen prescription drug abuse, including programs to train parents, educators, healthcare professionals, and other “Teen Influencers.”
Purdue developed RxSafetyMatters.org…
Purdue supported Northeast Communities Against Substance Abuse, Inc…
Purdue provided the U.S. Conference of Mayors with a $225,000 grant…
Purdue provided the U.S. Conference of Mayors with a $225,000 grant to fund its “Safeguard My Meds Prescription Drug Abuse Prevention Recognition Program.” This program awards cities with outstanding local initiatives that have the greatest potential to reduce the misuse and abuse of prescription drugs, particularly among young people.
Purdue partnered with the National Education Association Health Information Network and provided grants totaling approximately $500,000…
Purdue delivered the U.S. Surgeon General’s “TurnTheTideRx” materials to prescribers…
Purdue shared CDC Tear Sheets with prescribers…
Purdue provided a $3.1 million grant to form a public-private partnership with the Commonwealth of Virginia…
Purdue entered into a two-year collaborative research partnership with the University of Oklahoma…
In partnership with University of Nebraska, Purdue supported scholarships…
Purdue has collaborated with the NIH and NIDA on a public-private partnership as part of the “Helping to End Addiction Long-term” (HEAL) initiative…
Since 2017, Purdue has collaborated with the National Institutes of Health (NIH) and the National Institute on Drug Abuse (NIDA) on a public-private partnership as part of the “Helping to End Addiction Long-term” (HEAL) initiative to advance treatments for opioid use disorder and non-opioid, non-addictive pain medications.